Annual Scientific Sessions

Related by string. * annual . annuals . ANNUAL . Annuals : Annual Screen Actors . MOST RECENTLY FILED ANNUAL . Annual Shareholder Meeting . seasonally adjusted annual / SCIENTIFIC . Scientifics . scientifi c : UN Educational Scientific . Scientific Advisory Board . scientific journal Nature / SESSION . SESSIONS . sessions : Jeff Sessions . lame duck session . Session Initiated Protocol SIP * *

Related by context. All words. (Click for frequent words.) 82 Scientific Sessions 77 ASH Annual Meeting 76 Hematology ASH Annual Meeting 76 Hematology Annual Meeting 75 Scientific Session 75 AHA Scientific Sessions 75 annual Transcatheter Cardiovascular 74 Clinical Oncology Annual Meeting 74 ADA Scientific Sessions 74 Gastrointestinal Cancers Symposium 73 nd Annual Meeting 72 Therapeutics TCT scientific 72 Digestive Disease Week 72 CTRC AACR San Antonio 72 Rheumatology ACR Annual 71 Annual Transcatheter Cardiovascular 71 Digestive Disease Week DDW 71 Genitourinary Cancers Symposium 70 ASCO Annual Meeting 69 AACR San Antonio 69 AUA Annual Meeting 69 Hematology ASH 69 AACR #nd Annual Meeting 69 AACR #st Annual Meeting 69 Symposium SABCS 69 Clinical Oncology ASCO Annual 68 Scientific Meeting 68 Transcatheter Cardiovascular Therapeutics TCT 68 Prostate Cancer Symposium 68 Therapeutics TCT 68 Breast Cancer Symposium 67 Hematology Meeting 67 Vascular Annual Meeting 67 Nephrology Renal Week 67 Arteriosclerosis Thrombosis 67 Rheumatology Annual 67 Digestive Diseases Week 67 Medical Oncology ESMO 67 #nd Annual Meeting 66 AACR Annual Meeting 66 Infectious Diseases ECCMID 66 AACR Meeting 66 AAN Annual Meeting 66 #st Annual Meeting 66 AAO HNSF Annual Meeting 66 st Annual Meeting 66 EORTC NCI AACR Symposium 66 ASCO GI 66 Related Disorders ICAD 65 Breast Cancer Symposium SABCS 65 Endocrine Society ENDO 65 Society CTOS 65 Neurology Annual Meeting 65 Gastroenterology ACG Annual 65 Cancers Symposium 65 Cardiology ACC 64 ICAAC 64 Opportunistic Infections CROI 64 Cardiology Scientific Sessions 64 Chemotherapy ICAAC 64 ASCO Genitourinary Cancers Symposium 64 #th Annual Interscience 64 League Against Rheumatism 64 Connective Tissue Oncology 64 & OTO EXPO 63 ERA EDTA 63 AACR NCI EORTC 63 Molecular Targets 63 ACR ARHP Annual 63 #rd Annual CTRC 63 European CanCer Organisation ECCO 63 Midyear Clinical Meeting 63 Oncology ASTRO 63 Gastrointestinal Cancer 63 Microbiology ASM 63 Cancer iSBTc 63 Vascular Biology ATVB 63 Neurology AAN 63 Interventions SCAI 63 Transcatheter Cardiovascular Therapeutics 63 Cardiostim 63 EuroPCR 62 Endocrine Society Annual Meeting 62 Late Breaker 62 ISPOR 62 Therapeutic Radiology 62 SABCS 62 Annual ICAAC 62 Retroviruses 62 Immunology Annual Meeting 62 Heart Failure Society 62 Advanced Neuroendocrine Tumors 62 Annual Interscience Conference 61 Antimicrobial Agents 61 Gene Therapy ASGT 61 Annual Meeting 61 Association EHA 61 Endocrine Society #nd 61 ACR ARHP 61 Opportunistic Infections 61 AASLD Meeting 61 Hematology ASH Meeting 61 International Myeloma Workshop 61 Molecular Medicine Tri 61 AACR IASLC Joint 61 ECTRIMS 61 ASTRO Annual Meeting 61 ASMS Conference 60 Biological Therapy 60 Neck Surgery Foundation 60 UEGW 60 Diabetes EASD 60 BIOCOM Investor Conference 60 Liver EASL 60 Interventional Radiology SIR 60 Cardiovascular Disease Epidemiology 60 ACC.# 60 AAPS Annual Meeting 60 Malignant Lymphoma 60 HFSA Annual 60 Pediatric Academic Societies 60 AABB Annual Meeting 60 Pharmaceutical Scientists AAPS 60 VEITHsymposium 60 CROI 60 American Thoracic Society 59 ECNP Congress 59 Clinical Endocrinologists AACE 59 #nd EORTC NCI 59 ECCMID 59 Interscience Conference 59 Neurological Surgeons Annual Meeting 59 EORTC NCI 59 ICAAC IDSA 59 EVEREST II 59 ® DDW 59 Hypertension ASH 59 AACR Frontiers 59 Clinical Oncology Gastrointestinal Cancers 59 SAEM Annual Meeting 59 EULAR Annual 59 Rheumatology Annual Meeting 59 AAAAI Annual Meeting 59 Liver Diseases AASLD 59 America HFSA 59 Clinical Oncology ASCO 58 ASCO Breast Cancer 58 Gastroenterology ACG 58 DDW ® 58 EACTS 58 ASBMR 58 Research IADR 58 Alzheimer Disease ICAD 58 AASLD 58 PreCISe 58 Clinical Trial Results 58 PROactive Study 58 Retrovirus Conference 58 Pediatric Academic Societies PAS 58 ENDEAVOR III 58 Radiation Oncology ASTRO 58 Breaking Clinical Trials 58 Chicago Multidisciplinary Symposium 57 Rheumatology ACR 57 ORAL Sync 57 ESMO 57 Clinical Microbiology 57 Haemostasis ISTH 57 Human Genetics ASHG 57 Clinical Oncology ASCO Gastrointestinal 57 Anesthesiologists Annual Meeting 57 #th Interscience Conference 57 Neuromodulation Society 57 American Roentgen Ray 57 Endocrine Society #st 57 Postgraduate Course 57 EORTC NCI AACR 57 Edge STudy 57 Annual BIO 57 Randomized Phase 57 Phase 2a Study 57 Abstract Number 57 SCAI Annual 57 Mass Spectrometry ASMS 56 EASL 56 Clinical Oncologists 56 Preclinical Data 56 TG MV 56 Pediatric Academic Society 56 AVERROES 56 CHEST 56 Phase III AFFIRM 56 ENDO 56 ExTRACT TIMI 56 San Antonio Breast Cancer 56 America RSNA 56 ASCO GU 56 Poster Session 56 GTCbio 56 Endovascular Therapy ISET 56 DIA Annual Meeting 56 Gynecologic Cancer Society 56 USpella 56 Selective Cardiac Myosin Activator 56 Targeted Anticancer Therapies 56 Oral Fingolimod 56 GASTRO 56 & Immunology AAAAI 56 HORIZONS AMI trial 56 BIO InvestorForum 56 Cambridge Healthtech Institute 56 Oligonucleotide Therapeutics Society 56 Venereology EADV 55 Multilateral Initiative 55 Cystic Fibrosis Conference NACFC 55 Oral Presentation 55 ECCO ESMO 55 Epilepsy Society 55 Endovascular Valve Edge 55 Therapeutic Radiation 55 Annual CTRC AACR 55 Experimental Biology EB 55 Preclinical Study 55 RECORD1 55 SPIRIT IV 55 Annual Canaccord Adams 55 CLEO QELS 55 Cell Biology ASCB 55 Selective Cardiac Myosin 55 Spine Arthroplasty Society 55 Cancer Therapeutic 55 Poster Discussion 55 AACR 55 assessing T DM1 55 II Clinical Trial 55 Ophthalmology ARVO 55 Canaccord Adams Hepatitis C 55 Cardiac Techniques 55 System Pharmacists ASHP 55 Urology EAU 55 #King Bong Paul 55 International Papillomavirus 55 Minimally Invasive Gynecology 55 ongoing Phase 1b 55 Cardiology ESC Congress 55 Drugs Affecting Lipid 55 Applied Spectroscopy 55 Multiple Sclerosis ECTRIMS 55 Antiviral Research 55 Annual LD MICRO 55 Cardiology ESC 55 AACR symposium 55 Epileptology 55 Mineral Research ASBMR 55 Nephrology Annual Meeting 54 MEND CABG 54 Phase III placebo controlled 54 Experimental Biology Annual Meeting 54 Nephrology ASN Renal 54 Lung Cancer IASLC 54 SPIRIT FIRST 54 Neuro Oncology SNO 54 HIV Pathogenesis Treatment 54 EFORT Congress 54 Atrial Fibrillation Symposium 54 Neurology AAN Annual Meeting 54 Global Healthcare Unplugged 54 Liver Disease AASLD 54 Respiratory Society 54 rd Annual 54 Poster Presentations 54 HORIZONS AMI 54 ABSORB 54 EMBLEM TM 54 Fifth Decennial International 54 Anesthesiologists ASA Annual Meeting 54 RIO Lipids 54 ARVO 54 Integrative Oncology 54 Combination REOLYSIN R 54 PERSEUS 54 International Microwave Symposium 54 ROCKET AF 54 Phase III ALLEGRO 54 Symposium Seminar 54 Cachexia 54 Phase 2b Clinical Trial 54 Aggressive Reduction 54 Movement Disorder 54 registrational Phase 54 Stem Cell Research ISSCR 54 Initiated Phase 54 i2 Summit 54 EFNS 54 AACR Symposium 54 Neurological Surgeons AANS 54 ASGT 54 Multiethnic Study 54 International Verapamil SR 54 CARE HF 54 Echocardiography ASE 54 SAWC WHS 53 Targeted Therapies 53 bazedoxifene conjugated estrogens 53 Nordic ACTI 53 Retina Specialists ASRS 53 Oncology ESTRO 53 randomized multicenter trial 53 PERSEUS clinical program 53 GRNCM1 53 Acute Myocardial Infarction 53 EASD 53 Molecular Origins 53 Phase Ib study 53 Liver Diseases 53 Annual Institutional Investor 53 teriflunomide 53 Endourology 53 Solorel TM 53 TXPO 53 Female Urology 53 NASDAQ CYTK announced 53 Prospective Multicenter 53 Refractory Angina 53 ARRS Annual Meeting 53 CRLX# 53 PROSTVAC TM 53 MADIT II 53 Inc. Nasdaq ATHX 53 Neuropsychopharmacology ECNP 53 AAAS Annual Meeting 53 transthyretin TTR mediated amyloidosis 53 Lung Cancer WCLC 53 Carotid Revascularization Endarterectomy vs. 53 Cardiovascular Therapeutics 53 Inc. Nasdaq OPTR 53 multicenter Phase 53 Chest Physicians ACCP 53 Cardiovascular Anesthesiologists 53 Phase 2a clinical 53 ASCO abstract 53 CTRC AACR 53 paclitaxel eluting stents 53 By Liam Hunn 53 Antithrombotic 53 Therapeutic Targets 53 Candy Bellinger Apr 53 Oral Presentations 53 Proc Am Soc 53 Lysosomal Disease Network 53 metastatic castration resistant 53 PROactive study 53 Midwinter Meeting 53 dose escalation clinical 53 Active Biotech NASDAQ OMX 53 Neuropsychopharmacology 53 Annual JMP Securities 53 Podium Presentation 53 PROVENGE sipuleucel T 53 Clinical Dermatology 53 Thoracic Surgeons STS 53 ASCO Gastrointestinal Cancers Symposium 53 Chemotherapy ICAAC Infectious Diseases 53 PCI ExTRACT TIMI 53 Stent Thrombosis 53 Cardiovascular Interventions 53 Annual OneMedForum 53 Rhinology 53 IEEE MTT S 53 fidaxomicin Phase 3 53 American Psychosomatic Society 53 International Neuropsychological Society 53 Owen Vater 53 novel VDA molecule 53 Phase III ADT 53 Clinical Virology Symposium 52 Completes Enrollment 52 By Brian Lofrumento 52 AIR2 Trial 52 Breaking Clinical Trial 52 Gaylord Palms Hotel 52 SPIE Photonics West 52 Dendritic Cells 52 Presents Preclinical 52 BRIM3 52 Ocular Pharmacology 52 Experimental Biology 52 Diana Haecker ~ 52 NSTI Nanotech 52 PFO migraine 52 journal Arteriosclerosis Thrombosis 52 Clinical Oncology 52 Endovascular Therapy 52 GTCbio 3rd 52 phase IIa clinical 52 Completes Patient Enrollment 52 ECNP 52 Breast Surgeons ASBS 52 OneMedPlace Finance Forum 52 ACUITY trial 52 Chest Physicians CHEST 52 Thermo Scientific booth 52 DU #b 52 Vascular Biology 52 Immunology ACAAI 52 PRNewswire FirstCall Tercica 52 Phase Ib II 52 CIMZIA TM certolizumab pegol 52 ZD# [001] 52 Interventional Radiological Society 52 www.asco.org 52 HIV Pathogenesis 52 By AAyles 52 number NCT# ClinicalTrials.gov 52 American Urological Association 52 Diabetologia 52 Phase #b/#a clinical 52 phase IIb study 52 Cardiovascular Horizons 52 Breast Surgeons 52 Aggressive Drug Evaluation 52 VEITHsymposium ™ 52 Natalizumab 52 Pooled Analysis 52 carotid artery stenting CAS 52 Clinical Chemistry AACC 52 BOLDER II 52 Ophthalmology AAO 52 Intervention Effectiveness 52 HDL Selective Delipidation 52 oral FTY# 52 Plenary Session 52 stent DES 52 Brentuximab Vedotin SGN 52 CALGB # [002] 52 Systemic Sclerosis 52 Gynecologic Investigation 52 By Matt Akersten 52 EULAR 52 Controlled Release 52 Annual EuroMeeting 52 Insulin Resistance Syndrome 52 sipuleucel T 52 PRNewswire FirstCall Amylin Pharmaceuticals 52 Biotech Showcase 52 Stocks Gapping Down 52 Neuropathic Pain 52 Phase 2a trial 52 HCV NS5B polymerase 52 ENDEAVOR IV 52 By Taimur Asad 52 SID Display Week 52 Canaccord Adams Musculoskeletal 52 Microplasmin 52 FIP Pharmaceutical 52 Ophthalmology ARVO Annual Meeting 52 Prostate AdenoCarcinoma Treatment 52 Biennial Meeting 52 ABRF 52 Clinical Trials Update 52 Hematology 52 th Interscience Conference 52 Delcath Phase III 52 evaluating tivozanib 52 Neurological Societies 52 PROTECT II 52 HeFT 52 CYPHER R Sirolimus eluting 52 International OARSI 52 Jewtastic Staff 52 Annual NewsMakers 52 AHIMA Convention 52 Multi Ethnic Study 52 Screening Trial 52 randomized controlled Phase 52 CTAP# Capsules 52 ERA D2C Convention 52 Presents Positive 52 Therapeutic Radiation Oncology 52 Professional Sleep Societies 52 Randomized Study 52 Heart Failure Therapies 52 HIF PHI 52 Clinical Antipsychotic Trials 52 Canaccord Genuity Musculoskeletal 52 entitled Synergistic 52 LD MICRO Conference 52 Poster Presentation 52 Announces Presentation 52 Respiratory Viral Infections 51 Menopause Society NAMS 51 IASLC 51 Announces Poster Presentations 51 INSPIRE Trial Phase III 51 Research AADR 51 Interventional Therapies 51 REALITY Trial 51 Bodog Beat Original 51 Platelet Inhibition 51 Medicine AAPM 51 Phase Ib clinical 51 Anesthesiologists ASA 51 Hsp# Inhibitor 51 Percutaneous Coronary Intervention 51 IL# PE#QQR 51 Randomized Clinical Trial 51 Inc. Nasdaq AMLN 51 By Frankie Genchi 51 acute PAO 51 HCV SPRINT 51 BRIM2 51 SPIRIT III 51 Fractional Flow Reserve 51 Cardiomyocytes 51 Plastic Surgeons ASPS Plastic 51 Safinamide 51 abstr 51 Outpatient Setting 51 ADVANCE PD 51 Pre RELAX AHF 51 Exhibitor Profiles 51 Glucosamine Chondroitin Arthritis 51 liposome injection 51 Electro Optics CLEO 51 ARVO Annual Meeting 51 Inc. Nasdaq ANDS 51 Overactive Bladder OAB 51 sirolimus eluting stents 51 chromium supplementation 51 riociguat 51 Val HeFT 51 Physiology Endocrinology 51 phase IIa 51 Meets Primary Endpoint 51 OTO EXPO 51 Antimicrobial Chemotherapy 51 multicenter trials 51 Nephrology CJASN 51 Immunology AAAAI 51 rALLy clinical trial 51 Phase #/#a 51 HIF PH inhibitors 51 Abbott bioabsorbable stent 51 NEVO RES 51 DDW 51 Multicenter 51 PITTCON 51 Metabolic Disorders 51 Phase III VISTA 51 Randomized Double blind 51 phase IIb trial 51 By NamNewsNetwork Jan 51 Phase 1b trial 51 Arch Intern Med 51 Refractive Surgery ASCRS 51 Vaccine Immunology 51 CYT# potent vascular disrupting 51 Ocular Inflammation 51 phase 2a 51 Inc. NASDAQ HEPH 51 pharmacokinetic PK 51 Double Blind Placebo 51 Phacilitate Vaccine Forum 51 Annual BioPartnering Europe 51 Phase III Clinical Trial 51 Pivotal Clinical Trial 51 statistically significant efficacy 51 First Patient Enrolled 51 Cholesterol Levels SPARCL 51 Thrombolytic Therapy 51 ISTH 51 SA FC# 51 SCCHN 51 Brachytherapy Society 51 LD Micro 51 EchoCRT 51 Lisofylline 51 oral rivaroxaban 51 Room #AB [002] 51 PRIMO CABG2 51 ESTRO 51 Biodetection Technologies 51 Biodefense Vaccines 51 Relapsing Multiple Sclerosis 51 SCTE Cable Tec EXPO 51 sorafenib tablets 51 Aflibercept 51 Arch Neurol 51 DASISION 51 NADA Convention 51 Ovarian PLCO Cancer 51 European CanCer Organisation 51 subanalysis 51 Radiological Society 51 Surgical Treatments 51 Haemostasis 51 Passing Offense #.# ypg 51 RE LY 51 #th Annual Retrovirus 50 By Kunal Gangar 50 System Pharmacists Midyear 50 KRN# 50 Phase IIB 50 Phase III Trial 50 Needham Biotechnology 50 metaglidasen 50 EINSTEIN DVT 50 Endoscopic Surgery 50 J Natl Cancer Inst 50 trial evaluating PRX# 50 By wildouble Posted 50 Circulation Cardiovascular Interventions 50 Asthma Intervention 50 RE LY trial 50 recurrent malignant glioma 50 maximally tolerated dose 50 Molecular Markers 50 Personalized Immunotherapy 50 acute STEMI 50 Coral Reef Symposium 50 AAICAD 50 non valvular atrial 50 Bucindolol 50 Andy Hemmington 50 Sipuleucel T 50 CTI Nasdaq 50 J Am Coll 50 MERLIN TIMI 50 taxane resistant 50 journal Antimicrobial Agents 50 mg administered orally 50 Gastroenterology Week UEGW 50 Neurological Surgeons CNS 50 prospective multicentre 50 Long Awaited Reality 50 Ophthalmology Annual Meeting 50 randomized controlled clinical 50 Castration Resistant Prostate Cancer 50 abstracts summarizing 50 delafloxacin 50 XIENCE V demonstrated 50 Optical Fiber Communication 50 Am J Epidemiol 50 Acute Heart Failure 50 Neuromuscular Diseases 50 Physiology Regulatory Integrative 50 Physiological Sciences 50 ASTEROID 50 Antiepileptic Drugs 50 Ranolazine 50 ORMD 50 TAXUS ATLAS 50 Environ Health Perspect 50 HCV RESPOND 2 50 Acquired Immune Deficiency Syndromes 50 ASCRS 50 Neuroendocrinology 50 ASCEND HF 50 By DJ Abisalih 50 SYNTAX trial 50 Abdominal Obesity 50 undergoing elective percutaneous 50 By TheImproper 50 Inflammatory Bowel Diseases 50 Digital Mammographic Imaging 50 CCX# 50 By Zain Alvi 50 ASCO 50 fidaxomicin Phase 50 MTT S 50 everolimus eluting stents 50 rivaroxaban Xarelto 50 mCRC patients 50 Clinical Efficacy 50 Cardiology 50 Hormone Refractory Prostate Cancer 50 Preclinical Efficacy 50 Reproductive Medicine ASRM 50 evaluating mipomersen 50 Diabetic Foot 50 Prospective Randomized 50 Sangamo BioSciences Announces 50 placebo controlled clinical 50 Biologic Therapy 50 Retina Specialists 50 PEGylated interferon beta 1a 50 Metastatic Melanoma 50 Surgeons ACS 50 Pivotal Trial 50 CLARITY TIMI 50 MERIT ES 50 SCTE Cable Tec Expo 50 ABCSG 50 Keystone Symposia 50 randomized Phase III 50 Orthopaedic Surgeons Annual Meeting 50 anti arrhythmic drug 50 Paediatric Oncology SIOP 50 preclinical efficacy 50 Patients Treated With 50 NASDAQ SLXP today 50 Coronary Artery Calcium 50 Deutsches Herzzentrum 50 #:#-# [031] 50 Transcatheter 50 Liver Meeting 50 Randomized Phase III 50 Cardiovascular Renal Physiology 50 Neuropsychopharmacology ACNP 50 CYPHER R Sirolimus Eluting 50 Nephrology ASN 50 fosbretabulin 50 comparing alemtuzumab 50 Institutional Investor Forum 50 Heart Rhythm 50 Lung Transplantation 50 BARI 2D 50 ST Elevation Myocardial 50 SU# [003] 50 Continence Society 50 Deke Marston 50 Phase 2a 50 IEEE Photovoltaic Specialists 50 Pharmacoeconomics 50 BioProcess International 50 DermTech International 50 Elagolix 50 chemotherapy gemcitabine 50 ThinkEquity Partners Growth 50 Neoplasia 50 Eluting Coronary Stent System 50 Phase Ib Clinical Trial 50 Catheterization 50 BIO# 50 phase Ib 50 vidofludimus 50 Novel Therapeutics 50 Inflammatory Arthritis 50 ASN Renal Week 50 multicenter placebo controlled 50 Abstract Accepted 50 Observational Study 50 Phase 2a Trial 50 alvespimycin 50 Carfilzomib 50 EURIDIS 50 phase IIb 50 Cell Transplant 50 Randomized Phase II 50 PRNewswire FirstCall Nektar Therapeutics 50 SUCCEED trial 50 substudy 50 Cancer Immunotherapy 50 Arch Surg 50 Therapeutic Advances 50 VESTASYNC 50 Abstract # 50 journal Hepatology 50 Maternal Fetal Medicine SMFM 50 Phase 1b 50 AACR EORTC NCI 50 Remote Sensing ASPRS 50 Kinase Inhibitor 49 Presents Preclinical Data 49 MobileFocus 49 verteporfin 49 Spine Society 49 ASH Abstract # 49 Controlled Trial 49 CAMMS# 49 Ahmed Umair 49 Thoracic Oncology 49 Cell Metabolism Cell 49 morphometric vertebral fractures 49 Thoracic Surgery AATS 49 Heart Assn 49 orally inhaled migraine 49 coronary stent merged 49 worsening thrombocytopenia 49 HIMSS Annual 49 Hernia Society 49 Intergroup Exemestane Study 49 PSN# [002] 49 Annual AIFA 49 multicenter randomized controlled 49 NASDAQ INHX 49 recurrent glioma 49 phase IIIb 49 Surgery ASLMS 49 Diabetes EASD Annual Meeting 49 Drug Formulation 49 Anti Tumor Activity 49 Mark Joyella #:# [002] 49 EADV 49 NYSE Amex RGN 49 Neuropharmacology 49 NAREIT REITWeek 49 Qrtr 49 Cardiovascular Angiography 49 prospective multicenter randomized 49 Acute Ischemic Stroke 49 Allergology 49 Heart Failure Patients 49 NO# [002] 49 ATVB 49 drug eluting stent DES 49 Endoscopic Surgeons SAGES 49 Free Full Text 49 Angiology 49 multicenter clinical 49 Phase 2a Clinical Trial 49 LibiGel testosterone gel 49 C# BioVentures 49 Tolvaptan 49 TORISEL TM 49 Physical Therapy PTJ 49 VoiceCon Spring 49 www.hematology.org 49 Inc. Nasdaq AVRX 49 CUSTOM III 49 Ladbrokes Poker Tournaments 49 catheter occlusion 49 EXPAREL ™ 49 retinal vein occlusion induced 49 Tanespimycin 49 huC# DM4 49 randomized Phase IIb 49 HCV Protease Inhibitor 49 PRNewswire FirstCall Ardea Biosciences 49 Suppl. 49 FOLFOX6 chemotherapy regimen 49 Science Translational Medicine 49 Phase #/#a trial 49 Percutaneous Cardiovascular Interventions 49 NASDAQ CXSP announced 49 Zenvia Phase III 49 vascular disrupting agent 49 Carotid Stenting 49 Optical Fiber Communications 49 Hypertension ESH 49 Coordinate Metrology Systems 49 Reports Preclinical Data 49 midstage clinical 49 Capsule Endoscopy 49 Canaccord Genuity Growth 49 Pirfenidone 49 REG2 49 Medicine NEJM 49 Symposium 49 Clin Chem 49 Perinatal Epidemiology 49 Minimally Invasive Spine Surgery 49 CombAT 49 viral kinetic 49 recurrent GBM 49 ESCRS 49 Pulmonary Arterial Hypertension 49 Safety Tolerability 49 Prostate Lung Colorectal 49 Diabet Med 49 NAASO 49 TASKi2 49 Midyear Meeting 49 IMPROVE HF 49 SoftScan R 49 PROSTASCINT R 49 www.aacr.org 49 randomized discontinuation trial 49 Am J Geriatr 49 Semafore Pharmaceuticals 49 MADIT CRT 49 Coronary Revascularization 49 FOLOTYN ® 49 HIMSS# Annual 49 Small Fuel Cells 49 Microalbuminuria 49 dual endothelin receptor antagonist 49 Artificial Organs 49 Hemodialysis Patients 49 Novalis Circle 49 Clinical Oncology JCO 49 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 49 Initiates Clinical Trial 49 LIGHTFAIR International 49 Concourse Exhibition Center 49 multicenter Phase II 49 Rosuvastatin 49 Endocrine Society 49 pertuzumab 49 Network HVTN 49 J Nutr 49 Therapeutics Roundtable 49 Solid Tumors 49 Eur Respir J 49 Valsartan 49 Astronomy Meeting 49 CIMZIA ™ 49 Intervention Effectiveness CATIE 49 Ann Rheum Dis 49 Photovoltaics Summit 49 NATRECOR ® 49 Central Retinal Vein 49 #-# Full Text 49 Mark Joyella #:# [001] 49 ECASS 49 Oncolytic Viruses 49 Cancer Cachexia 49 E CENP E 49 Society Midwinter Meeting 49 Intervention Trial GAIT 49 Related Viruses 49 ANN INTERN MED 49 Medtronic Endeavor stent 49 Ann Intern Med 49 Group RTOG 49 FASEB J. 49 Psychoneuroendocrinology 49 radezolid 49 Antibody Therapeutics 49 J.P. Morgan Healthcare 49 PPAI Expo 49 rALLy trial 48 Annual Piper Jaffray 48 Supercomputing Conference 48 Hand ASSH 48 prospective observational 48 CardioBip 48 NCVH 48 Acute MI 48 AVADO 48 Outcomes Research ISPOR 48 J Clin Oncol 48 R lenalidomide 48 Endeavor Drug Eluting 48 Radiology Imaging Network ACRIN 48 BY KIMBER SOLANA 48 Interactive Techniques 48 cetuximab Erbitux 48 HIMSS# 48 CALGB 48 Candesartan 48 multicentre prospective 48 Hedgehog Pathway Inhibitor 48 ILLUMINATE 48 Urology Devices Investment 48 HIMSS# Annual Conference 48 Flatotel Hotel 48 Hyperlipidemia 48 Guidelines Recommend 48 ISPE Annual Meeting 48 General Psychiatry #:#-#,# 48 IPC APEX Expo 48 Neurological Surgeons 48 ganetespib 48 Trial NLST 48 BioPharm America 48 HUPO 48 Urocortin 2 48 Echocardiography 48 HIMSS Healthcare 48 TAXUS IV 48 Drug Eluting Stents 48 RNAi Therapeutic 48 RAI Amsterdam 48 EORTC 48 everolimus eluting stent 48 ISHLT 48 Gynecologic Oncologists 48 Gynecol Oncol 48 Pyridorin 48 Patient Outcomes 48 APOPTONE 48 Neurotology 48 Br J Haematol 48 phase IIb clinical 48 LBH# 48 Headache Society 48 HQK 48 MYTHOS trial 48 PRNewswire FirstCall Genaera 48 LSE ASM 48 customizable drug eluting 48 Belimumab 48 Deforolimus 48 Cloretazine ® 48 Frankfurt XMP 48 IEEE Symposium 48 Advanced Heart Failure 48 TIDES Oligonucleotide 48 clevidipine 48 Dermatology AAD 48 Am J Pathol 48 candesartan cilexetil 48 BIO VentureForum East 48 Inc. Nasdaq BIOD 48 depsipeptide 48 Author Affiliations Division 48 BiTE antibody MT# 48 Nephrol Dial Transplant

Back to home page